{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:29:14Z","timestamp":1774513754355,"version":"3.50.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T00:00:00Z","timestamp":1173139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Genet"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1038\/nrg2005","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T09:30:15Z","timestamp":1173173415000},"page":"286-298","source":"Crossref","is-referenced-by-count":1719,"title":["Cancer epigenomics: DNA methylomes and histone-modification maps"],"prefix":"10.1038","volume":"8","author":[{"given":"Manel","family":"Esteller","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,3,6]]},"reference":[{"key":"BFnrg2005_CR1","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1056\/NEJMra023075","volume":"349","author":"JG Herman","year":"2003","unstructured":"Herman, J. G. & Baylin, S. B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349, 2042\u20132054 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrg2005_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrc1279","volume":"4","author":"AP Feinberg","year":"2004","unstructured":"Feinberg, A. P. & Tycko, B. The history of cancer epigenetics. Nature Rev. Cancer 4, 143\u2013153 (2004).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrg2005_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature02625","volume":"429","author":"G Egger","year":"2004","unstructured":"Egger, G., Liang, G., Aparicio, A. & Jones, P. A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457\u2013463 (2004).","journal-title":"Nature"},{"key":"BFnrg2005_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1146\/annurev.pharmtox.45.120403.095832","volume":"45","author":"M Esteller","year":"2005","unstructured":"Esteller, M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu. Rev. Pharmacol. Toxicol. 45, 629\u2013656 (2005).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"BFnrg2005_CR5","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1093\/nar\/29.22.4598","volume":"29","author":"CT Nguyen","year":"2001","unstructured":"Nguyen, C. T., Gonzales, F. A. & Jones, P. A. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res. 29, 4598\u20134606 (2001).","journal-title":"Nucleic Acids Res."},{"key":"BFnrg2005_CR6","first-page":"7213","volume":"62","author":"JA Fahrner","year":"2002","unstructured":"Fahrner, J. A., Eguchi, S., Herman, J. G. & Baylin, S. B. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res. 62, 7213\u20137218 (2002).","journal-title":"Cancer Res."},{"key":"BFnrg2005_CR7","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1093\/emboj\/cdg604","volume":"22","author":"E Ballestar","year":"2003","unstructured":"Ballestar, E. et al. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J. 22, 6335\u20136345 (2003).","journal-title":"EMBO J."},{"key":"BFnrg2005_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/ng1531","volume":"37","author":"MF Fraga","year":"2005","unstructured":"Fraga, M. F. et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nature Genet. 37, 391\u2013400 (2005). The first report of a common disruption of histone- modification patterns in cancer cells.","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR9","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1371\/journal.pgen.0020040","volume":"2","author":"K Pruitt","year":"2006","unstructured":"Pruitt, K. et al. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet. 2, e40 (2006).","journal-title":"PLoS Genet."},{"key":"BFnrg2005_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57\u201370 (2000).","journal-title":"Cell"},{"key":"BFnrg2005_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/2413","volume":"20","author":"CP Walsh","year":"1998","unstructured":"Walsh, C. P., Chaillet, J. R. & Bestor, T. H. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nature Genet. 20, 116\u2013117 (1998).","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1126\/science.1083558","volume":"300","author":"F Gaudet","year":"2003","unstructured":"Gaudet, F. et al. Induction of tumors in mice by genomic hypomethylation. Science 300, 489\u2013492 (2003).","journal-title":"Science"},{"key":"BFnrg2005_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/sj.embor.7400456","volume":"6","author":"M Esteller","year":"2005","unstructured":"Esteller, M. & Almouzni, G. How epigenetics integrates nuclear functions. Workshop on epigenetics and chromatin: transcriptional regulation and beyond. EMBO Rep. 6, 624\u2013628 (2005).","journal-title":"EMBO Rep."},{"key":"BFnrg2005_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrg1602","volume":"6","author":"W Reik","year":"2005","unstructured":"Reik, W. & Lewis, A. Co-evolution of X-chromosome inactivation and imprinting in mammals. Nature Rev. Genet. 6, 403\u2013410 (2005).","journal-title":"Nature Rev. Genet."},{"key":"BFnrg2005_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1517\/14712598.2.6.577","volume":"2","author":"B Bodey","year":"2002","unstructured":"Bodey, B. Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy. Expert Opin. Biol. Ther. 2, 577\u2013584 (2002).","journal-title":"Expert Opin. Biol. Ther."},{"key":"BFnrg2005_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ng886","volume":"31","author":"BW Futscher","year":"2002","unstructured":"Futscher, B. W. et al. Role for DNA methylation in the control of cell type specific maspin expression. Nature Genet. 31, 175\u2013179 (2002).","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR17","doi-asserted-by":"publisher","first-page":"11236","DOI":"10.1158\/0008-5472.CAN-05-2959","volume":"65","author":"A Kaneda","year":"2005","unstructured":"Kaneda, A. & Feinberg, A. P. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk. Cancer Res. 65, 11236\u201311240 (2005).","journal-title":"Cancer Res."},{"key":"BFnrg2005_CR18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/bies.10008","volume":"23","author":"PA Wade","year":"2001","unstructured":"Wade, P. A. Methyl CpG-binding proteins and transcriptional repression. BioEssays 23, 1131\u20131137 (2001).","journal-title":"BioEssays"},{"key":"BFnrg2005_CR19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/PL00000895","volume":"58","author":"JR Dobosy","year":"2001","unstructured":"Dobosy, J. R. & Selker, E. U. Emerging connections between DNA methylation and histone acetylation. Cell. Mol. Life Sci. 58, 721\u2013727 (2001).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnrg2005_CR20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/0470862637.ch2","volume":"259","author":"Y Wang","year":"2004","unstructured":"Wang, Y. et al. Beyond the double helix: writing and reading the histone code. Novartis Found. Symp. 259, 3\u201317 (2004).","journal-title":"Novartis Found. Symp."},{"key":"BFnrg2005_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2004.11.009","volume":"119","author":"SL Sanders","year":"2004","unstructured":"Sanders, S. L. et al. Methylation of histone H4 lysine 20 controls recruitment of Crb2 to sites of DNA damage. Cell 119, 603\u2013614 (2004).","journal-title":"Cell"},{"key":"BFnrg2005_CR22","doi-asserted-by":"publisher","first-page":"37175","DOI":"10.1074\/jbc.M404842200","volume":"279","author":"J Espada","year":"2004","unstructured":"Espada, J. et al. Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification pattern. J. Biol. Chem. 279, 37175\u201337184 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrg2005_CR23","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nature03672","volume":"435","author":"DB Seligson","year":"2005","unstructured":"Seligson, D. B. et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435, 1262\u20131266 (2005). The first profile of histone modifications in cancer with prognostic relevance.","journal-title":"Nature"},{"key":"BFnrg2005_CR24","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1146\/annurev.bi.56.070187.004023","volume":"56","author":"M Barbacid","year":"1987","unstructured":"Barbacid, M. ras genes. Annu. Rev. Biochem. 56, 779\u2013827 (1987).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnrg2005_CR25","doi-asserted-by":"publisher","first-page":"632","DOI":"10.2144\/02333rv01","volume":"33","author":"MF Fraga","year":"2002","unstructured":"Fraga, M. F. & Esteller, M. DNA methylation: a profile of methods and applications. Biotechniques 33, 632\u2013649 (2002).","journal-title":"Biotechniques"},{"key":"BFnrg2005_CR26","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1093\/nar\/22.15.2990","volume":"22","author":"SJ Clark","year":"1994","unstructured":"Clark, S. J., Harrison, J., Paul, C. L. & Frommer, M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22, 2990\u20132997 (1994).","journal-title":"Nucleic Acids Res."},{"key":"BFnrg2005_CR27","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"93","author":"JG Herman","year":"1996","unstructured":"Herman, J. G. et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA 93, 9821\u20139826 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrg2005_CR28","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1093\/nar\/28.8.e32","volume":"28","author":"CA Eads","year":"2000","unstructured":"Eads, C. A. et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28, e32 (2000).","journal-title":"Nucleic Acids Res."},{"key":"BFnrg2005_CR29","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1002\/elps.200290023","volume":"23","author":"K Uhlmann","year":"2002","unstructured":"Uhlmann, K. et al. Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis. Electrophoresis 23, 4072\u20134079 (2002).","journal-title":"Electrophoresis"},{"key":"BFnrg2005_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/72785","volume":"24","author":"JF Costello","year":"2000","unstructured":"Costello, J. F. et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nature Genet. 24, 132\u2013138 (2000). One of the first studies to define the number of hypermethylated CpG islands in cancer cells and their distribution according to tumour type.","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ng1007","volume":"32","author":"G Zardo","year":"2002","unstructured":"Zardo, G. et al. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nature Genet. 32, 453\u2013458 (2002).","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR32","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1093\/nar\/18.24.7213","volume":"18","author":"J Welsh","year":"1990","unstructured":"Welsh, J. & McClelland, M. Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res. 18, 7213\u20137218 (1990).","journal-title":"Nucleic Acids Res."},{"key":"BFnrg2005_CR33","first-page":"594","volume":"57","author":"ML Gonzalgo","year":"1997","unstructured":"Gonzalgo, M. L. et al. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 57, 594\u2013599 (1997).","journal-title":"Cancer Res."},{"key":"BFnrg2005_CR34","first-page":"2307","volume":"59","author":"M Toyota","year":"1999","unstructured":"Toyota, M. et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 59, 2307\u20132312 (1999).","journal-title":"Cancer Res."},{"key":"BFnrg2005_CR35","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1093\/nar\/30.7.e28","volume":"30","author":"J Frigola","year":"2002","unstructured":"Frigola, J., Ribas, M., Risques, R. A. & Peinado, M. A. Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS). Nucleic Acids Res. 30, e28 (2002).","journal-title":"Nucleic Acids Res."},{"key":"BFnrg2005_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/hmg\/8.3.459","volume":"8","author":"TH Huang","year":"1999","unstructured":"Huang, T. H., Perry, M. R. & Laux, D. E. Methylation profiling of CpG islands in human breast cancer cells. Hum. Mol. Genet. 8, 459\u2013470 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrg2005_CR37","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1101\/gr.5273806","volume":"16","author":"B Khulan","year":"2006","unstructured":"Khulan, B. et al. Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res. 16, 1046\u20131055 (2006).","journal-title":"Genome Res."},{"key":"BFnrg2005_CR38","doi-asserted-by":"publisher","first-page":"8342","DOI":"10.1158\/0008-5472.CAN-06-1932","volume":"66","author":"L Lopez-Serra","year":"2006","unstructured":"Lopez-Serra, L. et al. A profile of MBD protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer. Cancer Res. 66, 8342\u20138346 (2006).","journal-title":"Cancer Res."},{"key":"BFnrg2005_CR39","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/ng1598","volume":"37","author":"M Weber","year":"2005","unstructured":"Weber, M. et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nature Genet. 37, 853\u2013862 (2005). The first report of the use of methyl-DIP, a powerful epigenomic technique for identifying DNA-methylation changes in transformed cells.","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ng1719","volume":"38","author":"I Keshet","year":"2006","unstructured":"Keshet, I. et al. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nature Genet. 38, 149\u2013153 (2006). This paper reports extensive mapping of DNA-methylation changes in cancer cells using methyl-DIP.","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR41","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2006.08.003","volume":"126","author":"X Zhang","year":"2006","unstructured":"Zhang, X. et al. Genome-wide high-resolution mapping and functional analysis of DNA methylation in Arabidopsis. Cell 126, 1189\u20131201 (2006). A ground-breaking study that combines methyl-DIP and tiling arrays, providing the first example of an almost complete DNA methylome in one organism.","journal-title":"Cell"},{"key":"BFnrg2005_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ng892","volume":"31","author":"H Suzuki","year":"2002","unstructured":"Suzuki, H. et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nature Genet. 31, 141\u2013149 (2002).","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR43","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1535-6108(02)00215-5","volume":"2","author":"K Yamashita","year":"2002","unstructured":"Yamashita, K. et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2, 485\u2013495 (2002). References 42 and 43 describe pioneering studies that combine DNA-demethylating agents and expression microarrays to reveal methylation-associated silencing in cancer cells.","journal-title":"Cancer Cell"},{"key":"BFnrg2005_CR44","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1158\/0008-5472.CAN-03-4061","volume":"64","author":"MF Fraga","year":"2004","unstructured":"Fraga, M. F. et al. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res. 64, 5527\u20135534 (2004).","journal-title":"Cancer Res."},{"key":"BFnrg2005_CR45","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ng1820","volume":"38","author":"LP O'Neill","year":"2006","unstructured":"O'Neill, L. P., Vermilyea, M. D. & Turner, B. M. Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations. Nature Genet. 38, 835\u2013841 (2006).","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nature02651","volume":"430","author":"Z Lippman","year":"2004","unstructured":"Lippman, Z. et al. Role of transposable elements in heterochromatin and epigenetic control. Nature 430, 471\u2013476 (2004).","journal-title":"Nature"},{"key":"BFnrg2005_CR47","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.cell.2004.05.023","volume":"117","author":"SK Kurdistani","year":"2004","unstructured":"Kurdistani, S. K., Tavazoie, S. & Grunstein, M. Mapping global histone acetylation patterns to gene expression. Cell 117, 721\u2013733 (2004). A pioneering study in which histone-modification changes in yeast were analysed by ChIP-on-chip.","journal-title":"Cell"},{"key":"BFnrg2005_CR48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cell.2005.06.026","volume":"122","author":"DK Pokholok","year":"2005","unstructured":"Pokholok, D. K. et al. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122, 517\u2013527 (2005).","journal-title":"Cell"},{"key":"BFnrg2005_CR49","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1101\/gad.1198204","volume":"18","author":"D Schubeler","year":"2004","unstructured":"Schubeler, D. et al. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev. 18, 1263\u20131271 (2004).","journal-title":"Genes Dev."},{"key":"BFnrg2005_CR50","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/sj.emboj.7600545","volume":"24","author":"JH Martens","year":"2005","unstructured":"Martens, J. H. et al. The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 24, 800\u2013812 (2005).","journal-title":"EMBO J."},{"key":"BFnrg2005_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2005.01.001","volume":"120","author":"BE Bernstein","year":"2005","unstructured":"Bernstein, B. E. et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120, 169\u2013181 (2005).","journal-title":"Cell"},{"key":"BFnrg2005_CR52","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","volume":"125","author":"BE Bernstein","year":"2006","unstructured":"Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315\u2013326 (2006).","journal-title":"Cell"},{"key":"BFnrg2005_CR53","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/ncb1403","volume":"8","author":"V Azuara","year":"2006","unstructured":"Azuara, V. et al. Chromatin signatures of pluripotent cell lines. Nature Cell Biol. 8, 532\u2013538 (2006).","journal-title":"Nature Cell Biol."},{"key":"BFnrg2005_CR54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng1521","volume":"37","author":"L Yu","year":"2005","unstructured":"Yu, L. et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nature Genet. 37, 265\u2013274 (2005).","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR55","first-page":"3225","volume":"8","author":"M Esteller","year":"2001","unstructured":"Esteller, M., Corn, P. G., Baylin, S. B. & Herman, J. G. A gene hypermethylation profile of human cancer. Cancer Res. 8, 3225\u20133229 (2001). The most comprehensive analysis of promoter CpG-island hypermethylation in human cancer using a candidate-gene approach.","journal-title":"Cancer Res."},{"key":"BFnrg2005_CR56","first-page":"1114","volume":"63","author":"MF Paz","year":"2003","unstructured":"Paz, M. F. et al. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 63, 1114\u20131121 (2003).","journal-title":"Cancer Res."},{"key":"BFnrg2005_CR57","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1126\/science.1133427","volume":"314","author":"T Sjoblom","year":"2006","unstructured":"Sjoblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268\u2013274 (2006).","journal-title":"Science"},{"key":"BFnrg2005_CR58","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/hmg\/ddg226","volume":"12","author":"MF Paz","year":"2003","unstructured":"Paz, M. F. et al. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases. Hum. Mol. Genet. 12, 2209\u20132219 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrg2005_CR59","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ccr.2006.04.020","volume":"9","author":"Y Saito","year":"2006","unstructured":"Saito, Y. et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9, 435\u2013443 (2006).","journal-title":"Cancer Cell"},{"key":"BFnrg2005_CR60","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1158\/0008-5472.CAN-06-4218","volume":"67","author":"A Lujambio","year":"2007","unstructured":"Lujambio, A. et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67, 1424\u20131429 (2007). References 59 and 60 describe the first examples of CpG-island methylation-associated silencing of microRNAs in human cancer.","journal-title":"Cancer Res."},{"key":"BFnrg2005_CR61","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ng1950","volume":"39","author":"Y Schlesinger","year":"2006","unstructured":"Schlesinger, Y. et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nature Genet. 39, 232\u2013236 (2006).","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/ng1941","volume":"39","author":"M Widschwendter","year":"2006","unstructured":"Widschwendter, M. et al. Epigenetic stem cell signature in cancer. Nature Genet. 39, 157\u2013158 (2006).","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR63","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.1065173","volume":"295","author":"L Di Croce","year":"2002","unstructured":"Di Croce, L. et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295, 1079\u20131082 (2002).","journal-title":"Science"},{"key":"BFnrg2005_CR64","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.297.5588.1807d","volume":"297","author":"M Esteller","year":"2002","unstructured":"Esteller, M. et al. Cancer epigenetics and methylation. Science 297, 1807\u20131808 (2002).","journal-title":"Science"},{"key":"BFnrg2005_CR65","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/sj.emboj.7600509","volume":"24","author":"C Brenner","year":"2005","unstructured":"Brenner, C. et al. Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 24, 336\u2013346 (2005).","journal-title":"EMBO J."},{"key":"BFnrg2005_CR66","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nature04431","volume":"439","author":"E Vire","year":"2006","unstructured":"Vire, E. et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871\u2013874 (2006).","journal-title":"Nature"},{"key":"BFnrg2005_CR67","doi-asserted-by":"publisher","first-page":"10014","DOI":"10.1073\/pnas.180316197","volume":"97","author":"VM Richon","year":"2000","unstructured":"Richon, V. M., Sandhoff, T. W., Rifkind R. A. & Marks, P. A. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc. Natl Acad. Sci. USA 97, 10014\u201310019 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrg2005_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.onc.1207316","volume":"23","author":"M Esteller","year":"2004","unstructured":"Esteller, M. & Herman, J. G. Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer. Oncogene 23, 1\u20138 (2004).","journal-title":"Oncogene"},{"key":"BFnrg2005_CR69","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4161\/cbt.5.1.2288","volume":"5","author":"VP Tryndyak","year":"2006","unstructured":"Tryndyak, V. P., Kovalchuk, O. & Pogribny, I. P. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4\u201320h2 histone methyltransferase and methyl-binding proteins. Cancer Biol. Ther. 5, 65\u201370 (2006).","journal-title":"Cancer Biol. Ther."},{"key":"BFnrg2005_CR70","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/carcin\/bgi364","volume":"27","author":"IP Pogribny","year":"2006","unstructured":"Pogribny, I. P. et al. Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4\u201320h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. Carcinogenesis 27, 1180\u20131186 (2006).","journal-title":"Carcinogenesis"},{"key":"BFnrg2005_CR71","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.277.5329.1100","volume":"277","author":"SE Jacobsen","year":"1997","unstructured":"Jacobsen, S. E. & Meyerowitz, E. M. Hypermethylated SUPERMAN epigenetic alleles in Arabidopsis. Science 277, 1100\u20131103 (1997).","journal-title":"Science"},{"key":"BFnrg2005_CR72","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/ng1664","volume":"37","author":"J Mager","year":"2005","unstructured":"Mager, J. & Bartolomei, M. S. Strategies for dissecting epigenetic mechanisms in the mouse. Nature Genet. 37, 1194\u20131200 (2005).","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR73","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-2164-7-90","volume":"7","author":"H Ozdag","year":"2006","unstructured":"Ozdag, H. et al. Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics 7, 90 (2006).","journal-title":"BMC Genomics"},{"key":"BFnrg2005_CR74","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/nar\/gkh252","volume":"32","author":"XJ Yang","year":"2004","unstructured":"Yang, X. J. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res. 32, 959\u2013976 (2004).","journal-title":"Nucleic Acids Res."},{"key":"BFnrg2005_CR75","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1158\/0008-5472.CAN-04-0050","volume":"64","author":"SD Moore","year":"2004","unstructured":"Moore, S. D. et al. Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF. Cancer Res. 64, 5570\u20135577 (2004).","journal-title":"Cancer Res."},{"key":"BFnrg2005_CR76","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0092-8674(01)00542-6","volume":"107","author":"AH Peters","year":"2001","unstructured":"Peters, A. H. et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107, 323\u2013337 (2001).","journal-title":"Cell"},{"key":"BFnrg2005_CR77","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/ng1773","volume":"38","author":"S Ropero","year":"2006","unstructured":"Ropero, S. et al. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nature Genet. 38, 566\u2013569 (2006). The first-described disruption of a histone deacetylase in human cancer provides a basis for further pharmacogenomic studies.","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR78","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1126\/science.310.5754.1615b","volume":"310","author":"H Varmus","year":"2005","unstructured":"Varmus, H. & Stillman, B. Support for the Human Cancer Genome Project. Science 310, 1615 (2005).","journal-title":"Science"},{"key":"BFnrg2005_CR79","doi-asserted-by":"publisher","first-page":"11733","DOI":"10.1073\/pnas.91.24.11733","volume":"91","author":"WH Lee","year":"1994","unstructured":"Lee, W. H. et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl Acad. Sci. USA 91, 11733\u201311737 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrg2005_CR80","first-page":"2727","volume":"7","author":"P Cairns","year":"2001","unstructured":"Cairns, P. et al. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin. Cancer Res. 7, 2727\u20132730 (2001).","journal-title":"Clin. Cancer Res."},{"key":"BFnrg2005_CR81","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1045","volume":"3","author":"PW Laird","year":"2003","unstructured":"Laird, P. W. The power and the promise of DNA methylation markers. Nature Rev. Cancer 3, 253\u2013266 (2003).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrg2005_CR82","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrc1799","volume":"6","author":"SB Baylin","year":"2006","unstructured":"Baylin, S. B. & Ohm, J. E. Epigenetic gene silencing in cancer \u2014 a mechanism for early oncogenic pathway addiction? Nature Rev. Cancer 6, 107\u2013116 (2006).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrg2005_CR83","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/carcin\/bgi152","volume":"26","author":"WM Gallagher","year":"2005","unstructured":"Gallagher, W. M. et al. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. Carcinogenesis 26, 1856\u20131867 (2005).","journal-title":"Carcinogenesis"},{"key":"BFnrg2005_CR84","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1093\/hmg\/10.26.3001","volume":"10","author":"M Esteller","year":"2001","unstructured":"Esteller, M. et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum. Mol. Genet. 10, 3001\u20133007 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrg2005_CR85","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/jnci\/djh224","volume":"96","author":"M Alaminos","year":"2004","unstructured":"Alaminos, M. et al. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. J. Natl Cancer Inst. 96, 1208\u20131219 (2004).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrg2005_CR86","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.lungcan.2004.08.003","volume":"47","author":"JA Tsou","year":"2005","unstructured":"Tsou, J. A. et al. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. Lung Cancer 47, 193\u2013204 (2005).","journal-title":"Lung Cancer"},{"key":"BFnrg2005_CR87","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1158\/1078-0432.CCR-05-1551","volume":"12","author":"SH Wei","year":"2006","unstructured":"Wei, S. H. et al. Prognostic DNA methylation biomarkers in ovarian cancer. Clin. Cancer Res. 12, 2788\u20132794 (2006).","journal-title":"Clin. Cancer Res."},{"key":"BFnrg2005_CR88","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","volume":"343","author":"M Esteller","year":"2000","unstructured":"Esteller, M. et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N. Engl. J. Med. 343, 1350\u20131354 (2000). The first translational use of a hypermethylated CpG island in the management of cancer patients.","journal-title":"N. Engl. J. Med."},{"key":"BFnrg2005_CR89","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi, M. E. et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352, 997\u20131003 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrg2005_CR90","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/jnci\/94.1.26","volume":"94","author":"M Esteller","year":"2002","unstructured":"Esteller, M. et al. Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J. Natl Cancer Inst. 94, 26\u201332 (2002).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrg2005_CR91","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/sj.bjc.6603024","volume":"94","author":"RM Glasspool","year":"2006","unstructured":"Glasspool, R. M., Teodoridis, J. M. & Brown, R. Epigenetics as a mechanism driving polygenic clinical drug resistance. Br. J. Cancer 94, 1087\u20131092 (2006).","journal-title":"Br. J. Cancer"},{"key":"BFnrg2005_CR92","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/jnci\/djj447","volume":"98","author":"GS Mack","year":"2006","unstructured":"Mack, G. S. Epigenetic cancer therapy makes headway. J. Natl Cancer Inst. 98, 1443\u20131444 (2006).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrg2005_CR93","first-page":"2168","volume":"63","author":"CA Thompson","year":"2006","unstructured":"Thompson, C. A. Vorinostat approved for rare lymphoma. Am. J. Health Syst. Pharm. 63, 2168 (2006).","journal-title":"Am. J. Health Syst. Pharm."},{"key":"BFnrg2005_CR94","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4161\/cc.5.4.2438","volume":"5","author":"S Seo","year":"2006","unstructured":"Seo, S. & Kroll, K. L. Geminin's double life: chromatin connections that regulate transcription at the transition from proliferation to differentiation. Cell Cycle 5, 374\u2013379 (2006).","journal-title":"Cell Cycle"},{"key":"BFnrg2005_CR95","doi-asserted-by":"publisher","first-page":"11241","DOI":"10.1158\/0008-5472.CAN-05-3865","volume":"65","author":"PA Jones","year":"2005","unstructured":"Jones, P. A. & Martienssen, R. A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop. Cancer Res. 65, 11241\u201311246 (2005).","journal-title":"Cancer Res."},{"key":"BFnrg2005_CR96","doi-asserted-by":"publisher","first-page":"11229","DOI":"10.1158\/0008-5472.CAN-65-24-ED1","volume":"65","author":"FJ Rauscher","year":"2005","unstructured":"Rauscher, F. J. It is time for a Human Epigenome Project. Cancer Res. 65, 11229 (2005).","journal-title":"Cancer Res."},{"key":"BFnrg2005_CR97","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/jnci\/djj042","volume":"98","author":"K Garber","year":"2006","unstructured":"Garber, K. Momentum building for Human Epigenome Project. J. Natl Cancer Inst. 98, 84\u201386 (2006).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrg2005_CR98","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/carcin\/bgl033","volume":"27","author":"M Esteller","year":"2006","unstructured":"Esteller, M. The necessity of a Human Epigenome Project. Carcinogenesis 27, 1121\u20131125 (2006).","journal-title":"Carcinogenesis"},{"key":"BFnrg2005_CR99","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/ng1929","volume":"39","author":"D Zilberman","year":"2006","unstructured":"Zilberman, D. et al. Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nature Genet. 39, 61\u201369 (2006). A high-resolution map of the A . thaliana DNA methylome that addresses its relationship to gene-expression patterns.","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR100","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1371\/journal.pbio.0020405","volume":"2","author":"VK Rakian","year":"2004","unstructured":"Rakian, V. K. et al. DNA methylation profiling of the human major histocompatibility complex: a pilot study for the Human Epigenome Project. PLoS Biol. 2, e405 (2004).","journal-title":"PLoS Biol."},{"key":"BFnrg2005_CR101","doi-asserted-by":"publisher","first-page":"10604","DOI":"10.1073\/pnas.0500398102","volume":"102","author":"MF Fraga","year":"2005","unstructured":"Fraga, M. F. et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl Acad. Sci. USA 102, 10604\u201310609 (2005). A comprehensive epigenomic study that demonstrates the presence of DNA methylation and histone modifications in individuals who have the same genetic background.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrg2005_CR102","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/ng1781","volume":"38","author":"J Frigola","year":"2006","unstructured":"Frigola, J. et al. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nature Genet. 38, 540\u2013549 (2006).","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR103","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/ng1923","volume":"38","author":"N Stransky","year":"2006","unstructured":"Stransky, N. et al. Regional copy number-independent deregulation of transcription in cancer. Nature Genet. 38, 1386\u20131396 (2006).","journal-title":"Nature Genet."},{"key":"BFnrg2005_CR104","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/ng1909","volume":"38","author":"F Eckhardt","year":"2006","unstructured":"Eckhardt, F. et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nature Genet. 38, 1378\u20131385 (2006).","journal-title":"Nature Genet."}],"container-title":["Nature Reviews Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrg2005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrg2005","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrg2005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T13:30:10Z","timestamp":1707658210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrg2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,6]]},"references-count":104,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["BFnrg2005"],"URL":"https:\/\/doi.org\/10.1038\/nrg2005","relation":{},"ISSN":["1471-0056","1471-0064"],"issn-type":[{"value":"1471-0056","type":"print"},{"value":"1471-0064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,6]]}}}